Human Medicines Regulations 2012
| Statutory Instrument | |
| Citation | SI 2012/1916 |
|---|---|
| Territorial extent | United Kingdom |
| Dates | |
| Made | 19 July 2012 |
| Laid before Parliament | 24 July 2012 |
| Commencement | 14 August 2012 |
| Other legislation | |
| Amends | |
| Transposes | Directive 2010/84/EU |
| Amended by | Human Medicines (Coronavirus and Influenza) (Amendment) Regulations 2020 |
Status: Amended | |
| Text of statute as originally enacted | |
| Revised text of statute as amended | |
| Text of the Human Medicines Regulations 2012 as in force today (including any amendments) within the United Kingdom, from legislation.gov.uk. | |
The Human Medicines Regulations 2012 (SI 2012/1916) in the United Kingdom were created, under statutory authority of the European Communities Act 1972 and the Medicines Act 1968 in 2012. The body responsible for their upkeep is the Medicines and Healthcare products Regulatory Agency. The regulations partially repealed the Medicines Act 1968 in line with EU legislation.